Primary care data sharpens the picture of PLE in Pugs: full analysis

A new UK VetCompass study is giving clinicians a clearer picture of how protein-losing enteropathy plays out for Pugs in everyday practice, not just in referral hospitals. Published online January 25, 2026, in the Journal of Small Animal Practice, the retrospective analysis examined 51 Pugs diagnosed with PLE between 2017 and 2024 and found that 22 dogs, or 43.1%, died presumed due to the disease. More than half of those deaths happened within three months of diagnosis, underscoring how quickly these cases can deteriorate. (pubmed.ncbi.nlm.nih.gov)

That mortality signal fits with a broader pattern already emerging in the literature. In a 2024 Journal of Veterinary Internal Medicine study of 107 dogs hospitalized with PLE, Pugs had significantly higher in-hospital mortality than other breeds, with most of those deaths attributed to presumptive aspiration pneumonia. That earlier work suggested the breed may face a particularly difficult course once severely affected, and highlighted the need to prevent and rapidly recognize respiratory complications in these patients. (pubmed.ncbi.nlm.nih.gov)

The new study is notable because it shifts the lens to primary care. Using UK first-opinion clinical records from VetCompass, the authors found that 21 of 51 Pugs, or 41.2%, were referred for specialist care, while the rest were managed in general practice. Thirty-four dogs received prednisolone, 14 received clopidogrel, six received chlorambucil, and two received cyclosporin. Pugs that were alive at three months were more likely than those that died within that period to have been treated with prednisolone or clopidogrel. Referral status, by contrast, was not associated with a statistically significant survival difference at three months, one year, or two years. (pubmed.ncbi.nlm.nih.gov)

That doesn't mean referral is unnecessary. The authors explicitly note that studies accounting for disease severity are still needed before clinicians can conclude that primary care and referral management truly produce equivalent outcomes. In practice, it's plausible that some less severe cases remained in first-opinion care, while more unstable or diagnostically complex dogs were referred, which could blur true differences between groups. The study's value is less about settling that question than about showing that meaningful PLE management is already happening in primary care, and that outcomes there deserve closer attention. (pubmed.ncbi.nlm.nih.gov)

Industry coverage from Vet Candy emphasized the same takeaway: this was real-world evidence from general practice, and it pointed to early, aggressive medical therapy as a potentially important lever in a disease with high early mortality. That framing is consistent with the paper's treatment findings, though the associations should still be interpreted cautiously because the study was retrospective and not designed to prove causation. (myvetcandy.com)

Why it matters: For veterinary teams, especially those in first-opinion small animal practice, the study reinforces that a Pug with chronic gastrointestinal signs, hypoalbuminemia, or suspected thromboembolic risk may need fast escalation in diagnostic thinking and treatment planning. The apparent short-term survival association with prednisolone and clopidogrel may influence how clinicians think about early medical management, while the prior evidence around aspiration pneumonia in Pugs adds another layer to inpatient and outpatient monitoring. Just as important, the paper validates primary care data as clinically useful evidence, giving practices a more realistic benchmark for what PLE outcomes can look like outside tertiary centers. (pubmed.ncbi.nlm.nih.gov)

For pet parents, this may also shape conversations about prognosis and referral. A guarded prognosis remains appropriate, but the study suggests that non-referral care is not automatically futile when referral isn't possible. That could help clinicians frame options more honestly: referral may still be warranted for unstable, atypical, or nonresponsive cases, but prompt treatment in general practice may still matter substantially in the first weeks after diagnosis. This is especially relevant in a disease where early mortality is concentrated in the first three months. (pubmed.ncbi.nlm.nih.gov)

What to watch: The next step is better-quality evidence, particularly prospective studies that stratify by disease severity, define treatment protocols more clearly, and test whether the prednisolone and clopidogrel signal holds up. Clinicians should also watch for further work on breed-specific complications in Pugs, especially aspiration pneumonia and other factors that may worsen survival independent of GI disease control. (pubmed.ncbi.nlm.nih.gov)